Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias M Peters

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Psychology|June 11, 2025
Interacting with fallible AI: is distrust helpful when receiving AI misclassifications?Tobias M Peters, Ingrid Scharlau
Frontiers in Psychology|January 19, 2026
Assessing healthy distrust in human-AI interaction: interpreting changes in visual attentionTobias M Peters, Kai Biermeier, Ingrid Scharlau
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 15, 2017
Color Pupillography in Dorsal Midbrain SyndromeCarina B Kelbsch, Fumiatsu Maeda, Torsten Strasser, et al.
Open Research Europe|August 30, 2023
The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patientsPatty P A Dhooge, Philipp T Möller, Camiel J F Boon, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Psychology|June 11, 2025
Interacting with fallible AI: is distrust helpful when receiving AI misclassifications?Tobias M Peters, Ingrid Scharlau
Frontiers in Psychology|January 19, 2026
Assessing healthy distrust in human-AI interaction: interpreting changes in visual attentionTobias M Peters, Kai Biermeier, Ingrid Scharlau
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|July 15, 2017
Color Pupillography in Dorsal Midbrain SyndromeCarina B Kelbsch, Fumiatsu Maeda, Torsten Strasser, et al.
Open Research Europe|August 30, 2023
The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patientsPatty P A Dhooge, Philipp T Möller, Camiel J F Boon, et al.
Pageof 1